Gary Emmanuel has market leading experience in corporate securities matters, representing both domestic and foreign companies in a full range of general corporate and securities matters, with a focus on navigating the process of capital raising, including initial public offerings (IPOs), follow-on offerings, shelf takedowns, private placements in public equities (PIPEs), reverse mergers, and de-SPACs, as well as SEC reporting and compliance, and corporate governance matters. Gary works closely with life science companies and other companies in growth technology verticals, both as company counsel and as underwriter’s counsel. In addition, Gary counsels companies in a wide variety of corporate transactions including licensing, reverse mergers, acquisitions, and joint ventures.
Based in Tel Aviv, Gary is highly experienced in working with the Israeli business community and assisting Israeli companies with their US corporate matters, with special emphasis on capital markets related transactions.
- Capital markets
- Public and private offerings, including IPOs
- Special Purpose Acquisition Companies (SPACs)
- Securities Exchange Act reporting and compliance obligations
- Pharma, medical device, digital health and other life science
- Israel practice